人結腸癌細胞甲氨蝶呤耐藥株HT29 MTX

細胞名稱

人結腸癌細胞甲氨蝶呤耐藥株HT29 MTX

貨物編碼

BFN60803898

產品規格

T25培養瓶x1

1.5ml凍存管x2

細胞數量

1x10^6

1x10^6

保存溫度

37℃

-198℃

運輸方式

常溫保溫運輸

干冰運輸

安全等級

1

用途限制

僅供科研           3類

培養體系

DMEM高糖培養基+10%FBS+1%雙抗 

培養溫度

37℃

二氧化碳濃度

5%

簡介

人結腸癌細胞甲氨蝶呤耐藥株HT29 MTX，野生株取自44歲女性，該細胞耐藥倍數15倍，IC50 2100ng/ml

注釋

Heterozygous for APC p.Glu853Ter (c.2557G>T) and p.Thr1556fs*3 (c.4666_4667insA) (from parent cell line).

Heterozygous for BRAF p.Val600Glu (c.1799T>A) (from parent cell line).

Heterozygous for PIK3CA p.Pro449Thr (c.1345C>A) (from parent cell line).

Homozygous for SMAD4 p.Gln311Ter (c.931C>T) (from parent cell line).

Homozygous for TP53 p.Arg273His (c.818G>A) (from parent cell line).

STR信息

Amelogenin        X

CSF1PO        11,12

D2S1338        19,23

D3S1358        15,17

D5S818        11,12

D7S820        10

D8S1179        10 (AddexBio; CLS; PubMed=19372543; PubMed=25877200)

10,16 (CCRID; PubMed=11416159)

D13S317        11 (AddexBio; CLS)

11,12 (ATCC; CCRID; Cosmic-CLP; DSMZ; ECACC; KCLB; PubMed=19372543; PubMed=25877200; PubMed=25926053)

D16S539        11,12

D18S51        13

D19S433        14

D21S11        29,30

FGA        20,22

Penta D        11,13

Penta E        14,16

TH01        6,9

TPOX        8,9

vWA        17,19

參考文獻

PubMed=29101300; DOI=10.15252/msb.20177701

Frejno M., Zenezini Chiozzi R., Wilhelm M., Koch H., Zheng R., Klaeger S., Ruprecht B., Meng C., Kramer K., Jarzab A., Heinzlmeir S., Johnstone E., Domingo E., Kerr D., Jesinghaus M., Slotta-Huspenina J., Weichert W., Knapp S., Feller S.M., Kuster B.

Pharmacoproteomic characterisation of human colon and rectal cancer.

Mol. Syst. Biol. 13:951-951(2017)

PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747

Dutil J., Chen Z., Monteiro A.N., Teer J.K., Eschrich S.A.

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Cancer Res. 79:1263-1273(2019)

PubMed=31068700; DOI=10.1038/s41586-019-1186-3

Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C., McDonald E.R. III, Barretina J., Gelfand E.T., Bielski C.M., Li H., Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F., Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R., Lu Y., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C., Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A., Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D., Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L., Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A., Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D., Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M., Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R., Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A., Sellers W.R.

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Nature 569:503-508(2019)

PubMed=31978347; DOI=10.1016/j.cell.2019.12.023

Nusinow D.P., Szpyt J., Ghandi M., Rose C.M., McDonald E.R. III, Kalocsay M., Jane-Valbuena J., Gelfand E., Schweppe D.K., Jedrychowski M., Golji J., Porter D.A., Rejtar T., Wang Y.K., Kryukov G.V., Stegmeier F., Erickson B.K., Garraway L.A., Sellers W.R., Gygi S.P.

Quantitative proteomics of the Cancer Cell Line Encyclopedia.

Cell 180:387-402(2020)